At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 126 enrolled
Drug / intervention
Penciclovir +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Double-blind, Vehicle Controlled, Single Center, Parallel Group, Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers
In Brief
A Phase 4 clinical trial evaluating Penciclovir and Placebo for Cold Sore. Completed, enrolled 126 participants across 1 site.
Detailed Summary
Comparison of the efficacy of penciclovir 10 mg/g (1%) cream with that of vehicle at 72 hours in preventing the appearance of classical lesions following prodromal symptoms (tingling or burning sensation) based on thermographic assessment among recurrent cold sore sufferers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCold Sore
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2008
First PostedJan 2009
Primary CompletionNov 2009
TodayJul 2026
First PostedJan 12, 2009
Enrollment StartDec 1, 2008
Primary CompletionNov 1, 2009
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 17.5 years ago
Interventions
Penciclovirdrug
Penciclovir every 2 hours during waking hours for 96 hours
Placebodrug
Placebo every 2 hous during waking hours for 96 hours